| Date Filed | Type | Description |
| 06/16/2023 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 64,000 options to buy
@ $3.27, valued at
$209.3k
|
|
| 06/16/2022 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 13,179 options to buy
@ $8.9, valued at
$117.3k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Converted 1,104,209 shares
@ $0
Converted 1,200,228 shares
@ $0
Bought 450,000 shares
@ $20, valued at
$9M
Converted 1,104,209 preferred shares
@ $0
Converted 1,200,228 preferred shares
@ $0 |
|
| 02/04/2021 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc. |
| 11/12/2020 |
4
| POWELL MICHAEL (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $10.95, valued at
$328.5k
|
|
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2020 |
4
| POWELL MICHAEL (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 13,179 options to buy
@ $9.31, valued at
$122.7k
|
|
| 06/03/2020 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 100,000 shares
@ $1.6912, valued at
$169.1k
Sold 400,000 shares
@ $1.6074, valued at
$643k
|
|
| 01/23/2020 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted options to buy
@ $1750000, valued at
$0 |
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2019 |
4
| POWELL MICHAEL (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 19,776 options
@ $12, valued at
$237.3k
|
|
| 11/06/2019 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Galera Therapeutics, Inc. |
| 06/07/2019 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 10,000 options to buy
@ $7.3, valued at
$73k
|
|
| 05/15/2019 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on NextCure, Inc.|
Txns:
| Converted 278,759 shares
@ $0
Converted 464,599 shares
@ $0
Converted 908,785 shares
@ $0
Converted 469,713 shares
@ $0
Bought 400,000 shares
@ $15, valued at
$6M
Converted 2,239,500 preferred shares
@ $0
Converted 3,732,500 preferred shares
@ $0
Converted 7,301,000 options to buy
@ $0
Converted 3,773,585 preferred shares
@ $0 |
|
| 05/08/2019 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on NextCure, Inc. |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 09/20/2018 |
4
| Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Converted 625,482 shares
@ $0
Converted 521,235 shares
@ $0
Converted 453,954 shares
@ $0
Converted 167,537 shares
@ $0
Bought 270,000 shares
@ $17, valued at
$4.6M
Converted 625,482 preferred shares
@ $0
Converted 521,235 preferred shares
@ $0
Converted 453,954 options to buy
@ $0
Converted 167,537 preferred shares
@ $0 |
|
| 09/13/2018 |
3
| Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 3 on Principia Biopharma Inc. |
| 06/14/2018 |
4
| POWELL MICHAEL (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 10,000 options to buy
@ $9.36, valued at
$93.6k
|
|
| 05/30/2018 |
4
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 721,408 shares
@ $0
Converted 275,446 shares
@ $0
Converted 229,660 shares
@ $0
Bought 500,000 shares
@ $13, valued at
$6.5M
Converted 721,408 options to buy
@ $0
Converted 275,446 options to buy
@ $0
Converted 229,660 options to buy
@ $0 |
|
| 05/24/2018 |
3
| Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc |
|